Evang. Kliniken Essen-Mitte gGmbh

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Bladder cancer1 trial
• Colorectal cancer1 trial
• COPD1 trial
• Gastric and oesophageal cancer1 trial
• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Bristol-Myers Squibb1 trial
• Exscientia AI Limited1 trial
• Georg Nilius, Prof DR med1 trial
• Hoffmann-La Roche1 trial
• and 1 more

Running trials

• Recruiting

  Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

  NCT07311083· Kliniken Essen-Mitte· Source

  Contact: Petra Voiss, PD Dr.

• Recruiting

  Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  NCT06324357· Phase 1/2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

  NCT06068738· Exscientia AI Limited· Source

• Completed

  Efficacy of Telemetry-assisted Care in Home Home Vented COPD

  NCT05287555· Georg Nilius, Prof DR med· Source

• Completed

  An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

  NCT02632409· Phase 3· Bristol-Myers Squibb· Source